Browse > Article
http://dx.doi.org/10.4070/kcj.2011.41.1.46

Management of a Remnant Electrode in a Patient With Cardioverter-Defibrillator Infection After Refusal of Intravascular Electrode Removal  

Hahn, Sung-Hwahn (Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University)
Kim, Ji-Hwan (Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University)
Choi, Jung-Hyun (Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University)
Lim, Seong-Hoon (Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University)
Kang, Tae-Soo (Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University)
Park, Byoung-Eun (Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University)
Lee, Myung-Yong (Division of Cardiology, Department of Internal Medicine, School of Medicine, Dankook University)
Publication Information
Korean Circulation Journal / v.41, no.1, 2011 , pp. 46-50 More about this Journal
Abstract
Treatments of choice for cardiac implantable electronic device (CIED) infections are the removal of the entire CIED system, control of infection, and new device implantation. Occasionally, a complete CIED removal can not be performed for several reasons, such as very old age, severe comobidity, limited life expectancy, or refusal by a patient. We encountered a male patient who developed traumatic CIED infection five years after cardioverter-defibrillator implantation. An intravenous electrode could not be removed by a simple transvenous extraction procedure, and he refused surgical removal of the remnant electrode. After control of local infection, the tips of the electrode were separated and buried between muscles, and the wound was closed with a local flap. CIED infection did not recur for 12 months even without relying on long-term antimicrobial treatment.
Keywords
Defibrillators, implantable; Infection; Electrodes, implanted;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Sohail MR, Uslan DZ, Kahn AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008;83:46-53.   DOI   ScienceOn
2 Baman TS, Gupta SK, Valle JA, Yamata E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol 2009;2:129-34.   DOI   ScienceOn
3 de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009;2:29-34.   DOI   ScienceOn
4 Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009;95:715-20.   DOI   ScienceOn
5 Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006;29:142-5.   DOI   ScienceOn
6 Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007;45:166-73.   DOI   ScienceOn
7 Klug D, Balde M, Pavin D, et al. Risk factor related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007;116:1349-55.   DOI   ScienceOn
8 Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796-801.   DOI   ScienceOn
9 Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients' outcome and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiary. J Am Coll Cardiol 2005;46:1536-40.   DOI   ScienceOn
10 Chamis AL, Perteson GE, Cabell CH, et al. Staphylococcus aureus bateremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104:1029-33.   DOI   ScienceOn
11 Kapa S, Hyberger L, Rea RF, Hayes DL. Complication risk with pulse generator change: implications when reacting to a device advisory or recall. Pacing Clin Electrophysiol 2007;30:730-3.   DOI   ScienceOn
12 Choi HS, Rhee MY, Choi YJ, et al. Long-term follow-up of the patients with permanent antibradycardia pacemaker. Korean Circ J 1998; 28:768-73.   DOI
13 Choi KJ, Lee CW, Kim JJ, Kim YH. Implantable cardioverter-defibrillator (ICD) therapy in a patient with the long QT syndrome. Korean Circ J 1996;26:1198-203.
14 Kim DH, Kim SY, Lee KH, et al. Follow-up of a group of patients with automatic implantable defibrillator. Korean Circ J 2005;35:69-83.
15 Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604-8.   DOI   ScienceOn
16 Sohail MR, Uslan DZ, Kahn AH, et al. Management and outcome of permanent and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49:1851-9.   DOI   ScienceOn
17 Love CJ, Wilkoff BL, Byrd CL, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads; in-dications, facilities, training. Pacing Clin Electrophysiol 2000;23: 544-51.   DOI   ScienceOn
18 Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation 2003;108:2015-31.   DOI   ScienceOn
19 Gaynor SL, Zierer A, Lawton JS, Gleva MJ, Damiano RJ Jr, Moon MR. Laser assistance for extraction of chronically implanted endocardial leads: infectious versus noninfectious indications. Pacing Clin Electrophysiol 2006;29:1352-8.   DOI   ScienceOn
20 Field ME, Jones SO, Epstein LM. How to select patients for lead extraction. Heart Rhythm 2007;4:978-85.   DOI   ScienceOn
21 Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604-8.   DOI   ScienceOn
22 Sopena B, Crespo M, Beiras X, et al. Individualized management of bacteraemia in patients with a permanent endocardial pacemaker. Clin Microbiol Infect 2010;16:274-80.   DOI   ScienceOn
23 Baddour LM. Long-term suppressive antimicrobial therapy for intravascular device-related infections. Am J Med Sci 2001;322:209-12.   DOI   ScienceOn
24 Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010;121:458-77.   DOI   ScienceOn
25 Trappe HJ, Pfitzner P, Klein H, Wenzlaff P. Infections after cardioverter-defibrillator implantation: observations in 335 patients over 10 years. Br Heart J 1995;73:20-4.   DOI
26 Lai KK, Fontecchio SA. Infections associated with implantable cardioverter-defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis 1998; 27:265-9.   DOI   ScienceOn
27 Gould PA, Krahn AD; Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 2006;295:1907-11.   DOI   ScienceOn
28 O'Nunain S, Perez I, Roelke M, et al. The treatment of patients with infected implantable cardioverter-defibrillator systems. J Thorac Cardiovasc Surg 1997;113:121-9.   DOI   ScienceOn